Profile | GDS4284 / 215498_s_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 4233.73 | 92 |
GSM687648 | Patient 402 control | 6397.52 | 95 |
GSM687653 | Patient 403 control | 2818.23 | 88 |
GSM687658 | Patient 404 control | 4252.04 | 92 |
GSM687663 | Patient 411 control | 4888.4 | 93 |
GSM687668 | Patient 422 control | 5285.66 | 94 |
GSM687673 | Patient 424 control | 9374.68 | 97 |
GSM687678 | Patient 425 control | 4232.7 | 92 |
GSM687683 | Patient 427 control | 6251.97 | 95 |
GSM687688 | Patient 428 control | 4439.16 | 92 |
GSM687695 | Patient 441 control | 31167.4 | 99 |
GSM687699 | Patient 443 control | 5558.47 | 94 |
GSM687704 | Patient 444 control | 4764.49 | 93 |
GSM687707 | Patient 448 control | 3681.87 | 91 |
GSM687712 | Patient 449 control | 4591.44 | 93 |
GSM687719 | Patient 450 control | 7263.7 | 96 |
GSM687724 | Patient 451 control | 4641.17 | 93 |
GSM687728 | Patient 452 control | 4886.33 | 93 |
GSM687646 | Patient 401 treated 24h | 2741.83 | 88 |
GSM687649 | Patient 402 treated 24h | 4919.46 | 93 |
GSM687665 | Patient 411 treated 24h | 6996.63 | 95 |
GSM687651 | Patient 402 treated 4 weeks | 6768.57 | 95 |
GSM687667 | Patient 411 treated 4 weeks | 4004.54 | 91 |
GSM687670 | Patient 422 treated 24h | 4593.72 | 93 |
GSM687671 | Patient 422 treated 4 weeks | 5050.56 | 93 |
GSM687654 | Patient 403 treated 24h | 3661.61 | 91 |
GSM687675 | Patient 424 treated 24h | 10201.3 | 97 |
GSM687685 | Patient 427 treated 24h | 6187.33 | 95 |
GSM687656 | Patient 403 treated 4 weeks | 3720.54 | 91 |
GSM687677 | Patient 424 treated 4 weeks | 7134.28 | 96 |
GSM687687 | Patient 427 treated 4 weeks | 2564.45 | 87 |
GSM687692 | Patient 428 treated 4h | 3433.29 | 90 |
GSM687716 | Patient 449 treated 4h | 3650.17 | 91 |
GSM687722 | Patient 450 treated 4h | 8940.87 | 97 |
GSM687680 | Patient 425 treated 24h | 4402.1 | 92 |
GSM687690 | Patient 428 treated 24h | 3778.72 | 91 |
GSM687700 | Patient 443 treated 24h | 14585 | 98 |
GSM687705 | Patient 444 treated 24h | 4399.23 | 92 |
GSM687714 | Patient 449 treated 24h | 4178.83 | 92 |
GSM687721 | Patient 450 treated 24h | 15721.1 | 98 |
GSM687682 | Patient 425 treated 4 weeks | 3405.92 | 90 |
GSM687694 | Patient 428 treated 4 weeks | 5114.54 | 93 |
GSM687702 | Patient 443 treated 4 weeks | 6283.69 | 95 |
GSM687718 | Patient 449 treated 4 weeks | 4356.92 | 92 |
GSM687723 | Patient 450 treated 4 weeks | 5980.06 | 95 |
GSM687661 | Patient 404 treated 4h | 4746.79 | 93 |
GSM687710 | Patient 448 treated 4h | 5317.83 | 94 |
GSM687726 | Patient 451 treated 4h | 5617.44 | 94 |
GSM687730 | Patient 452 treated 4h | 20916.2 | 99 |
GSM687660 | Patient 404 treated 24h | 14048.5 | 98 |
GSM687697 | Patient 441 treated 24h | 14322.8 | 98 |
GSM687709 | Patient 448 treated 24h | 4086.93 | 92 |
GSM687725 | Patient 451 treated 24h | 7266.36 | 96 |
GSM687729 | Patient 452 treated 24h | 14105 | 98 |
GSM687727 | Patient 451 treated 4 weeks | 6536.17 | 95 |
GSM687731 | Patient 452 treated 4 weeks | 4539.51 | 93 |